You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
回盛生物(300871.SZ):2020年度淨利預增110%-130%
格隆匯 01-11 16:15

格隆匯1月11日丨回盛生物(300871.SZ)披露2020年度業績預吿,預計2020年度營業收入7.48億元-8.33億元,同比增長75%-95%;歸屬於上市公司股東的淨利潤1.44億元–1.58億元,同比增長110%-130%。業績變動原因如下:

1、本報吿期內,營業收入和歸屬於上市公司股東的淨利潤均增幅較大,主要原因:

(1)公司抓住獸藥市場需求旺盛的有利時機,提升生產效能,營業收入大幅增長,歸屬於上市公司股東的淨利潤相應增加;

(2)公司不斷提升產品質量,強化技術服務,產品市場認可度提高,集團客户直銷和渠道經銷均取得較大突破,公司訂單充足;

(3)公司佈局上游原料藥效果顯現,保障生產原料供應及時可靠,同時原料藥對外銷售同比增長。

2、報吿期內,預計非經常性損益對公司淨利潤的影響金額為1281萬元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account